Patent Watch: Avecho Targets Oral Cannabinoid Delivery With Phosphorylated Tocopherols
Avecho’s application describes an oral cannabinoid formulation combining tocopheryl phosphates with long-chain triglycerides or long-chain fatty acids. Cannabinoids are the intended active pharmaceutical ingredients, while the accompanying compounds…
Patent Watch: Defloria Targets Autism With CW1AS1 Cannabinoid Extract
The application identifies a cannabinoid extract designated CW1AS1 for treating autism and associated symptoms. The available disclosure does not specify active pharmaceutical ingredients, cannabinoid ratios, excipients, dosing, or delivery mechanisms,…
Patent Watch: Lonza Pairs Cannabinoids With Musculoskeletal Nutrition
The application appears to claim a cannabinoid-containing product combined with collagen or related protein and lipid components for musculoskeletal health, potentially across human nutrition and animal feed applications. Cannabinoids are the principal…
“Love at First Dose: The Endocannabinoid System’s Surprising Role”
…
United Center Becomes First Major US Arena to Partner with Cannabis Drink Brands
The cannabis beverage market has reached a historic milestone with the United Center becoming the first major US arena to partner with cannabis drink brands. This partnership establishes the first official THC sponsorship at a major American venue. It…
